SA
PLSE icon

Sanctuary Advisors’s Pulse Biosciences PLSE Stock Holding History

Sanctuary Advisors’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-17,757
Closed -$244K – 2603
2025
Q4 		$244K Buy
+17,757
New +$277K ﹤0.01% 2151

Other funds holding PLSE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
GAM
Griffin Asset Management New York $887M AUM 21.42% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

Sanctuary Advisors's PLSE Position: Q1 2026 in Review

Sanctuary Advisors sold out of Pulse Biosciences (PLSE) in Q1 2026, closing a stake of 17,757 shares — an estimated $244K sold.

Sanctuary Advisors first reported a position in PLSE in Q4 2025 and held it in 1 quarter. The position peaked at $244K in Q4 2025. 96 funds tracked by Wall St. Rank hold PLSE as of Q1 2026.

  • Sanctuary Advisors reported no remaining Pulse Biosciences position as of Q1 2026 after selling out during the quarter.
  • Sanctuary Advisors sold 17,757 Pulse Biosciences shares in Q1 2026, an estimated $244K.
  • Sanctuary Advisors first reported a position in Pulse Biosciences in Q4 2025 and held it in 1 quarter.
  • Sanctuary Advisors's Pulse Biosciences position peaked at $244K in Q4 2025.
  • 96 funds tracked by Wall St. Rank held Pulse Biosciences as of Q1 2026.

Based on Sanctuary Advisors's 13F filing for Q1 2026, filed 5 May 2026.